The trademark Zomylac was filed by MACURE PHARMA ApS, a corporation established under the laws of the Kingdom of Denmark (the "Applicant"). The application was published for oppositions on August 29, 2021, and received one opposition filed on October 26, 2021 by OPKO HEALTH SPAIN, S.L.U. on Likelihood of confusion. the opponent was represented by HERRERO & ASOCIADOS and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued October 26, 2021
The application was filed in Danish, and Danish was also language of all opposition proceedings (English was selected as the second language).